| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 232.28B | 228.96B | 213.37B | 194.37B | 181.25B | 168.24B |
| Gross Profit | 91.35B | 90.02B | 86.65B | 76.57B | 75.71B | 72.44B |
| EBITDA | 31.62B | 31.16B | 29.73B | 25.34B | 27.70B | 27.05B |
| Net Income | 17.88B | 17.71B | 15.15B | 10.06B | 27.77B | 13.42B |
Balance Sheet | ||||||
| Total Assets | 209.25B | 209.99B | 223.64B | 205.23B | 220.87B | 202.91B |
| Cash, Cash Equivalents and Short-Term Investments | 24.43B | 31.06B | 49.90B | 36.36B | 60.33B | 31.57B |
| Total Debt | 24.00B | 20.19B | 20.32B | 20.44B | 10.98B | 10.92B |
| Total Liabilities | 83.48B | 77.59B | 90.99B | 79.37B | 89.70B | 79.20B |
| Stockholders Equity | 124.16B | 130.87B | 131.20B | 124.57B | 130.03B | 122.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.82B | 21.08B | -16.27B | 9.52B | -7.73B |
| Operating Cash Flow | 0.00 | 10.76B | 30.17B | -2.97B | 24.82B | 12.13B |
| Investing Cash Flow | 0.00 | -9.84B | -5.34B | -14.21B | 9.31B | -19.86B |
| Financing Cash Flow | 0.00 | -18.01B | -14.07B | -7.35B | -5.94B | -4.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥230.99B | 12.35 | 13.33% | 3.47% | 4.21% | 23.86% | |
72 Outperform | ¥78.08B | 6.88 | ― | 1.55% | 5.78% | 14.23% | |
72 Outperform | ¥31.57B | 10.02 | ― | 1.23% | 6.74% | 29.20% | |
69 Neutral | ¥55.22B | 20.67 | ― | 4.63% | 7.74% | 0.96% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | ¥31.13B | 48.79 | ― | 1.35% | 0.87% | -50.41% | |
49 Neutral | ¥63.66B | 14.49 | ― | 1.14% | 8.17% | 10.65% |